U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587008) titled 'Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers' on May 08.
Brief Summary: The objective of this study is to evaluate the pharmacokinetics (PK) and relative bioavailability of emraclidine following single oral administration of different immediate-release (IR) tablet formulations in healthy adult participants.
Study Start Date: May 11
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Emraclidine
Oral tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Disclaimer: Curated by HT Syndication....